期刊
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
卷 10, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2022.972933
关键词
aptamers; targeted drug delivery; cancer therapy; aptamer-drug conjugates (ApDCs); aptamer-based nanomaterial system
资金
- National Natural Science Foundation of Shanghai
- China NSFC
- [21ZR1422600]
- [2210070260]
Aptamer-embedded drug delivery systems have shown great potential in cancer therapy, as they can specifically bind to a variety of target molecules. They offer numerous advantages, including high biostability, versatile chemical modification, low immunogenicity, and strong tissue penetration. Therefore, they have attracted extensive interest in the field of precision medicine and hold significant importance for cancer treatment.
The past decade has become an important strategy in precision medicine for the targeted therapy of many diseases, expecially various types of cancer. As a promising targeted element, nucleic acid aptamers are single-stranded functional oligonucleotides which have specific abilities to bind with various target molecules ranging from small molecules to entire organisms. They are often named 'chemical antibody' and have aroused extensive interest in diverse clinical studies on account of their advantages, such as considerable biostability, versatile chemical modification, low immunogenicity and quick tissue penetration. Thus, aptamer-embedded drug delivery systems offer an unprecedented opportunity in bioanalysis and biomedicine. In this short review, we endeavor to discuss the recent advances in aptamer-based targeted drug delivery platforms for cancer therapy. Some perspectives on the advantages, challenges and opportunities are also presented.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据